Skip to main content
NCBI home page
Gut logoLink to Gut
. 1998 Jul;43(Suppl 1):S2–S5.

Bacterial factors and immune pathogenesis in Helicobacter pylori infection

T Shimoyama, J Crabtree
PMCID: PMC1766604  PMID: 9764030

Full Text

The Full Text of this article is available as a PDF (93.1 KB).

Figure 1 .

Figure 1

Open in a new tab

Induction of H pylori specific immune responses in the gastric mucosa. 


Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akopyants N. S., Clifton S. W., Kersulyte D., Crabtree J. E., Youree B. E., Reece C. A., Bukanov N. O., Drazek E. S., Roe B. A., Berg D. E. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol. 1998 Apr;28(1):37–53. doi: 10.1046/j.1365-2958.1998.00770.x. [DOI] [PubMed] [Google Scholar]
  2. Appelmelk B. J., Simoons-Smit I., Negrini R., Moran A. P., Aspinall G. O., Forte J. G., De Vries T., Quan H., Verboom T., Maaskant J. J. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun. 1996 Jun;64(6):2031–2040. doi: 10.1128/iai.64.6.2031-2040.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aspinall G. O., Monteiro M. A. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the O antigen and core oligosaccharide regions. Biochemistry. 1996 Feb 20;35(7):2498–2504. doi: 10.1021/bi951853k. [DOI] [PubMed] [Google Scholar]
  4. Aspinall G. O., Monteiro M. A., Pang H., Walsh E. J., Moran A. P. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry. 1996 Feb 20;35(7):2489–2497. doi: 10.1021/bi951852s. [DOI] [PubMed] [Google Scholar]
  5. Atherton J. C., Cao P., Peek R. M., Jr, Tummuru M. K., Blaser M. J., Cover T. L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995 Jul 28;270(30):17771–17777. doi: 10.1074/jbc.270.30.17771. [DOI] [PubMed] [Google Scholar]
  6. Atherton J. C., Peek R. M., Jr, Tham K. T., Cover T. L., Blaser M. J. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997 Jan;112(1):92–99. doi: 10.1016/s0016-5085(97)70223-3. [DOI] [PubMed] [Google Scholar]
  7. Beales I. L., Crabtree J. E., Scunes D., Covacci A., Calam J. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol. 1996 Jul;8(7):645–649. [PubMed] [Google Scholar]
  8. Bernatowska E., Jose P., Davies H., Stephenson M., Webster D. Interaction of campylobacter species with antibody, complement and phagocytes. Gut. 1989 Jul;30(7):906–911. doi: 10.1136/gut.30.7.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Berstad A. E., Brandtzaeg P., Stave R., Halstensen T. S. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut. 1997 Feb;40(2):196–203. doi: 10.1136/gut.40.2.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Birkholz S., Knipp U., Nietzki C., Adamek R. J., Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol Med Microbiol. 1993 Apr;6(4):317–324. doi: 10.1111/j.1574-695X.1993.tb00344.x. [DOI] [PubMed] [Google Scholar]
  11. Blaser M. J., Perez-Perez G. I., Kleanthous H., Cover T. L., Peek R. M., Chyou P. H., Stemmermann G. N., Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 1995 May 15;55(10):2111–2115. [PubMed] [Google Scholar]
  12. Bodger K., Wyatt J. I., Heatley R. V. Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut. 1997 Jun;40(6):739–744. doi: 10.1136/gut.40.6.739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Censini S., Lange C., Xiang Z., Crabtree J. E., Ghiara P., Borodovsky M., Rappuoli R., Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14648–14653. doi: 10.1073/pnas.93.25.14648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Covacci A., Censini S., Bugnoli M., Petracca R., Burroni D., Macchia G., Massone A., Papini E., Xiang Z., Figura N. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5791–5795. doi: 10.1073/pnas.90.12.5791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cover T. L., Blaser M. J. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem. 1992 May 25;267(15):10570–10575. [PubMed] [Google Scholar]
  16. Crabtree J. E., Covacci A., Farmery S. M., Xiang Z., Tompkins D. S., Perry S., Lindley I. J., Rappuoli R. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol. 1995 Jan;48(1):41–45. doi: 10.1136/jcp.48.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Crabtree J. E., Farmery S. M., Lindley I. J., Figura N., Peichl P., Tompkins D. S. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol. 1994 Oct;47(10):945–950. doi: 10.1136/jcp.47.10.945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Crabtree J. E. Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther. 1996 Apr;10 (Suppl 1):29–37. doi: 10.1046/j.1365-2036.1996.22164003.x. [DOI] [PubMed] [Google Scholar]
  19. Crabtree J. E., Shallcross T. M., Heatley R. V., Wyatt J. I. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut. 1991 Dec;32(12):1473–1477. doi: 10.1136/gut.32.12.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Crabtree J. E., Taylor J. D., Wyatt J. I., Heatley R. V., Shallcross T. M., Tompkins D. S., Rathbone B. J. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 1991 Aug 10;338(8763):332–335. doi: 10.1016/0140-6736(91)90477-7. [DOI] [PubMed] [Google Scholar]
  21. Crabtree J. E., Wyatt J. I., Sobala G. M., Miller G., Tompkins D. S., Primrose J. N., Morgan A. G. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut. 1993 Oct;34(10):1339–1343. doi: 10.1136/gut.34.10.1339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Crabtree J. E., Wyatt J. I., Trejdosiewicz L. K., Peichl P., Nichols P. H., Ramsay N., Primrose J. N., Lindley I. J. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol. 1994 Jan;47(1):61–66. doi: 10.1136/jcp.47.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Crabtree J. E., Xiang Z., Lindley I. J., Tompkins D. S., Rappuoli R., Covacci A. Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol. 1995 Oct;48(10):967–969. doi: 10.1136/jcp.48.10.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. D'Elios M. M., Manghetti M., Almerigogna F., Amedei A., Costa F., Burroni D., Baldari C. T., Romagnani S., Telford J. L., Del Prete G. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol. 1997 Jul;27(7):1751–1755. doi: 10.1002/eji.1830270723. [DOI] [PubMed] [Google Scholar]
  25. Evans D. J., Jr, Evans D. G., Lampert H. C., Nakano H. Identification of four new prokaryotic bacterioferritins, from Helicobacter pylori, Anabaena variabilis, Bacillus subtilis and Treponema pallidum, by analysis of gene sequences. Gene. 1995 Feb 3;153(1):123–127. doi: 10.1016/0378-1119(94)00774-m. [DOI] [PubMed] [Google Scholar]
  26. Evans D. J., Jr, Evans D. G., Takemura T., Nakano H., Lampert H. C., Graham D. Y., Granger D. N., Kvietys P. R. Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun. 1995 Jun;63(6):2213–2220. doi: 10.1128/iai.63.6.2213-2220.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Figura N., Guglielmetti P., Rossolini A., Barberi A., Cusi G., Musmanno R. A., Russi M., Quaranta S. Cytotoxin production by Campylobacter pylori strains isolated from patients with peptic ulcers and from patients with chronic gastritis only. J Clin Microbiol. 1989 Jan;27(1):225–226. doi: 10.1128/jcm.27.1.225-226.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Goodgame R. W., Malaty H. M., el-Zimaity H. M., Graham D. Y. Decrease in gastric permeability to sucrose following cure of Helicobacter pylori infection. Helicobacter. 1997 Mar;2(1):44–47. doi: 10.1111/j.1523-5378.1997.tb00057.x. [DOI] [PubMed] [Google Scholar]
  29. Haeberle H. A., Kubin M., Bamford K. B., Garofalo R., Graham D. Y., El-Zaatari F., Karttunen R., Crowe S. E., Reyes V. E., Ernst P. B. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun. 1997 Oct;65(10):4229–4235. doi: 10.1128/iai.65.10.4229-4235.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Harris P. R., Mobley H. L., Perez-Perez G. I., Blaser M. J., Smith P. D. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology. 1996 Aug;111(2):419–425. doi: 10.1053/gast.1996.v111.pm8690207. [DOI] [PubMed] [Google Scholar]
  31. Hatz R. A., Meimarakis G., Bayerdorffer E., Stolte M., Kirchner T., Enders G. Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol. 1996 Mar;31(3):222–228. doi: 10.3109/00365529609004870. [DOI] [PubMed] [Google Scholar]
  32. Hatz R. A., Rieder G., Stolte M., Bayerdörffer E., Meimarakis G., Schildberg F. W., Enders G. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology. 1997 Jun;112(6):1908–1919. doi: 10.1053/gast.1997.v112.pm9178683. [DOI] [PubMed] [Google Scholar]
  33. Ito Y., Azuma T., Ito S., Miyaji H., Hirai M., Yamazaki Y., Sato F., Kato T., Kohli Y., Kuriyama M. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol. 1997 Jul;35(7):1710–1714. doi: 10.1128/jcm.35.7.1710-1714.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Karttunen R., Karttunen T., Ekre H. P., MacDonald T. T. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut. 1995 Mar;36(3):341–345. doi: 10.1136/gut.36.3.341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Kobayashi K., Sakamoto J., Kito T., Yamamura Y., Koshikawa T., Fujita M., Watanabe T., Nakazato H. Lewis blood group-related antigen expression in normal gastric epithelium, intestinal metaplasia, gastric adenoma, and gastric carcinoma. Am J Gastroenterol. 1993 Jun;88(6):919–924. [PubMed] [Google Scholar]
  36. Kuipers E. J., Pérez-Pérez G. I., Meuwissen S. G., Blaser M. J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995 Dec 6;87(23):1777–1780. doi: 10.1093/jnci/87.23.1777. [DOI] [PubMed] [Google Scholar]
  37. Leunk R. D., Johnson P. T., David B. C., Kraft W. G., Morgan D. R. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol. 1988 Jun;26(2):93–99. doi: 10.1099/00222615-26-2-93. [DOI] [PubMed] [Google Scholar]
  38. Mohammadi M., Czinn S., Redline R., Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J Immunol. 1996 Jun 15;156(12):4729–4738. [PubMed] [Google Scholar]
  39. Moran A. P. The role of lipopolysaccharide in Helicobacter pylori pathogenesis. Aliment Pharmacol Ther. 1996 Apr;10 (Suppl 1):39–50. doi: 10.1046/j.1365-2036.1996.22164004.x. [DOI] [PubMed] [Google Scholar]
  40. Muotiala A., Helander I. M., Pyhälä L., Kosunen T. U., Moran A. P. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun. 1992 Apr;60(4):1714–1716. doi: 10.1128/iai.60.4.1714-1716.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Negrini R., Savio A., Poiesi C., Appelmelk B. J., Buffoli F., Paterlini A., Cesari P., Graffeo M., Vaira D., Franzin G. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology. 1996 Sep;111(3):655–665. doi: 10.1053/gast.1996.v111.pm8780570. [DOI] [PubMed] [Google Scholar]
  42. Nielsen H., Birkholz S., Andersen L. P., Moran A. P. Neutrophil activation by Helicobacter pylori lipopolysaccharides. J Infect Dis. 1994 Jul;170(1):135–139. doi: 10.1093/infdis/170.1.135. [DOI] [PubMed] [Google Scholar]
  43. Noach L. A., Bosma N. B., Jansen J., Hoek F. J., van Deventer S. J., Tytgat G. N. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol. 1994 May;29(5):425–429. doi: 10.3109/00365529409096833. [DOI] [PubMed] [Google Scholar]
  44. Parsonnet J., Friedman G. D., Orentreich N., Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997 Mar;40(3):297–301. doi: 10.1136/gut.40.3.297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Peek R. M., Jr, Miller G. G., Tham K. T., Perez-Perez G. I., Zhao X., Atherton J. C., Blaser M. J. Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab Invest. 1995 Dec;73(6):760–770. [PubMed] [Google Scholar]
  46. Sharma S. A., Tummuru M. K., Miller G. G., Blaser M. J. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Infect Immun. 1995 May;63(5):1681–1687. doi: 10.1128/iai.63.5.1681-1687.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tufano M. A., Rossano F., Catalanotti P., Liguori G., Capasso C., Ceccarelli M. T., Marinelli P. Immunobiological activities of Helicobacter pylori porins. Infect Immun. 1994 Apr;62(4):1392–1399. doi: 10.1128/iai.62.4.1392-1399.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tummuru M. K., Sharma S. A., Blaser M. J. Helicobacter pylori picB, a homologue of the Bordetella pertussis toxin secretion protein, is required for induction of IL-8 in gastric epithelial cells. Mol Microbiol. 1995 Dec;18(5):867–876. doi: 10.1111/j.1365-2958.1995.18050867.x. [DOI] [PubMed] [Google Scholar]
  49. Valnes K., Huitfeldt H. S., Brandtzaeg P. Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed human gastric mucosa. Gut. 1990 Jun;31(6):647–652. doi: 10.1136/gut.31.6.647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Weel J. F., van der Hulst R. W., Gerrits Y., Roorda P., Feller M., Dankert J., Tytgat G. N., van der Ende A. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis. 1996 May;173(5):1171–1175. doi: 10.1093/infdis/173.5.1171. [DOI] [PubMed] [Google Scholar]
  51. Wirth H. P., Yang M., Karita M., Blaser M. J. Expression of the human cell surface glycoconjugates Lewis x and Lewis y by Helicobacter pylori isolates is related to cagA status. Infect Immun. 1996 Nov;64(11):4598–4605. doi: 10.1128/iai.64.11.4598-4605.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yamaoka Y., Kita M., Kodama T., Sawai N., Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology. 1996 Jun;110(6):1744–1752. doi: 10.1053/gast.1996.v110.pm8964399. [DOI] [PubMed] [Google Scholar]
  53. Yamaoka Y., Kita M., Kodama T., Sawai N., Kashima K., Imanishi J. Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection. Scand J Gastroenterol. 1995 Dec;30(12):1153–1159. doi: 10.3109/00365529509101624. [DOI] [PubMed] [Google Scholar]
  54. Yasumoto K., Okamoto S., Mukaida N., Murakami S., Mai M., Matsushima K. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J Biol Chem. 1992 Nov 5;267(31):22506–22511. [PubMed] [Google Scholar]
  55. Ye G., Barrera C., Fan X., Gourley W. K., Crowe S. E., Ernst P. B., Reyes V. E. Expression of B7-1 and B7-2 costimulatory molecules by human gastric epithelial cells: potential role in CD4+ T cell activation during Helicobacter pylori infection. J Clin Invest. 1997 Apr 1;99(7):1628–1636. doi: 10.1172/JCI119325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Yoshida N., Granger D. N., Evans D. J., Jr, Evans D. G., Graham D. Y., Anderson D. C., Wolf R. E., Kvietys P. R. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology. 1993 Nov;105(5):1431–1440. doi: 10.1016/0016-5085(93)90148-6. [DOI] [PubMed] [Google Scholar]
  57. de Bernard M., Papini E., de Filippis V., Gottardi E., Telford J., Manetti R., Fontana A., Rappuoli R., Montecucco C. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem. 1995 Oct 13;270(41):23937–23940. doi: 10.1074/jbc.270.41.23937. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES